| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9820 |
| Human Intestinal Absorption | HIA+ | 0.9888 |
| Caco-2 Permeability | Caco2+ | 0.5375 |
| P-glycoprotein Substrate | Non-substrate | 0.9027 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9875 |
| Non-inhibitor | 0.9658 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9471 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7815 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8388 |
| CYP450 2D6 Substrate | Non-substrate | 0.8697 |
| CYP450 3A4 Substrate | Non-substrate | 0.7740 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.7345 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.8765 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9397 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9071 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9446 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9913 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9902 |
| Non-inhibitor | 0.9689 |
| AMES Toxicity | AMES toxic | 0.8544 |
| Carcinogens | Carcinogens | 0.5968 |
| Fish Toxicity | High FHMT | 0.6880 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.8841 |
| Honey Bee Toxicity | High HBT | 0.8591 |
| Biodegradation | Not ready biodegradable | 0.7146 |
| Acute Oral Toxicity | II | 0.5219 |
| Carcinogenicity (Three-class) | Non-required | 0.5962 |